BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12242729)

  • 1. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
    Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
    Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
    Zhou JR; Yu L; Mai Z; Blackburn GL
    Int J Cancer; 2004 Jan; 108(1):8-14. PubMed ID: 14618609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
    Zhou JR; Yu L; Zhong Y; Blackburn GL
    J Nutr; 2003 Feb; 133(2):516-21. PubMed ID: 12566493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
    Singh AV; Franke AA; Blackburn GL; Zhou JR
    Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
    Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
    Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
    Zaidman BZ; Wasser SP; Nevo E; Mahajna J
    Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells.
    Yu L; Blackburn GL; Zhou JR
    J Nutr; 2003 Feb; 133(2):389-92. PubMed ID: 12566472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
    Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
    Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
    Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
    Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
    Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
    Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
    Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
    Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
    Qiao Y; Zhang ZK; Cai LQ; Tan C; Imperato-McGinley JL; Zhu YS
    Prostate; 2007 Dec; 67(16):1719-28. PubMed ID: 17879940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
    Serafin AM; Akudugu JM; Bohm L
    Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
    Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
    J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer.
    Kampa M; Theodoropoulou K; Mavromati F; Pelekanou V; Notas G; Lagoudaki ED; Nifli AP; Morel-Salmi C; Stathopoulos EN; Vercauteren J; Castanas E
    J Pharmacol Exp Ther; 2011 Apr; 337(1):24-32. PubMed ID: 21205921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.